NCT05356637View on ClinicalTrials.gov

Bipolar Sealer for Reduction of Blood Loss in Anterior Total Hip Arthroplasties

NAActive, not recruitingINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

April 29, 2022

Primary Completion Date

January 31, 2024

Study Completion Date

February 1, 2024

Conditions
Osteoarthritis, HipBlood Loss
Interventions
DEVICE

Werewolf Fastseal 6.0

bi-polar hemostatic wand

Trial Locations (2)

75032

Texas Health Sugery Center - Rockwall, Rockwall

75088

Baylor Scott & White - Lake Pointe Medical Center, Rowlett

Sponsors
All Listed Sponsors
collaborator

Smith & Nephew, Inc.

INDUSTRY

lead

North Texas Medical Research Institute, PLLC

OTHER